Related references
Note: Only part of the references are listed.Stress and Host Immunity Amplify Mycobacterium tuberculosis Phenotypic Heterogeneity and Induce Nongrowing Metabolically Active Forms
Giulia Manina et al.
CELL HOST & MICROBE (2015)
The In Vivo Environment Accelerates Generation of Resuscitation-Promoting Factor-Dependent Mycobacteria
Obolbek Turapov et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
The Molecular Bacterial Load Assay Replaces Solid Culture for Measuring Early Bactericidal Response to Antituberculosis Treatment
Isobella Honeyborne et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Advancing the portfolio of tuberculosis diagnostics, drugs, biomarkers, and vaccines
Alimuddin I. Zumla et al.
LANCET INFECTIOUS DISEASES (2014)
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
Alimuddin I. Zumla et al.
LANCET INFECTIOUS DISEASES (2014)
The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
Veronique Dartois
NATURE REVIEWS MICROBIOLOGY (2014)
Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
Stephen H. Gillespie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
Amina Jindani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A high-resolution network model for global gene regulation in Mycobacterium tuberculosis
Eliza J. R. Peterson et al.
NUCLEIC ACIDS RESEARCH (2014)
Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism
Anil Koul et al.
NATURE COMMUNICATIONS (2014)
Radiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy Regimens
Philana Ling Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Microbial Persistence and the Road to Drug Resistance
Nadia R Cohen et al.
CELL HOST & MICROBE (2013)
Is repositioning of drugs a viable alternative in the treatment of tuberculosis?
Juan Carlos Palomino et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferase
Nuria Andreu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Direct Comparison of Xpert MTB/RIF Assay with Liquid and Solid Mycobacterial Culture for Quantification of Early Bactericidal Activity
Xavier A. Kayigire et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Tuberculosis biomarkers discovery: developments, needs, and challenges
Robert S. Wallis et al.
LANCET INFECTIOUS DISEASES (2013)
The Mycobacterium tuberculosis regulatory network and hypoxia
James E. Galagan et al.
NATURE (2013)
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
Kevin Pethe et al.
NATURE MEDICINE (2013)
Advances in the development of new tuberculosis drugs and treatment regimens
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Antimycobacterials from Lovage Root (Ligusticum officinale Koch)
Juan David Guzman et al.
PHYTOTHERAPY RESEARCH (2013)
A Humanized Mouse Model of Tuberculosis
Veronica E. Calderon et al.
PLOS ONE (2013)
Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers
Chloe I. Bloom et al.
PLOS ONE (2013)
Exploring the Mode of Action of Bioactive Compounds by Microfluidic Transcriptional Profiling in Mycobacteria
Paul Murima et al.
PLOS ONE (2013)
Dynamic Persistence of Antibiotic-Stressed Mycobacteria
Yuichi Wakamoto et al.
SCIENCE (2013)
Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay
Juan D. Guzman et al.
BMJ OPEN (2013)
A computational pipeline for quantification of pulmonary infections in small animal models using serial PET-CT imaging
Ulas Bagci et al.
EJNMMI RESEARCH (2013)
Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis
Ian M. Rosenthal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
An antibacterial from Hypericum acmosepalum inhibits ATP-dependent MurE ligase from Mycobacterium tuberculosis
Khadijo Osman et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections
Leonard Amaral et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
The chemotherapy of tuberculosis: past, present and future
D. Mitchison et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Synthesis and Biological Evaluation of Purpurealidin E-Derived Marine Sponge Metabolites: Aplysamine-2, Aplyzanzine A, and Suberedamines A and B
Suresh K. Kottakota et al.
JOURNAL OF NATURAL PRODUCTS (2012)
Versatile Routes to Marine Sponge Metabolites through Benzylidene Rhodanines
Suresh K. Kottakota et al.
ORGANIC LETTERS (2012)
Detectable Changes in The Blood Transcriptome Are Present after Two Weeks of Antituberculosis Therapy
Chloe I. Bloom et al.
PLOS ONE (2012)
Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide
Jacques Grosset et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials
Ben Gold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
MDR, XDR, TDR tuberculosis: ominous progression
Zarir F. Udwadia
THORAX (2012)
Comparative Studies Evaluating Mouse Models Used for Efficacy Testing of Experimental Drugs against Mycobacterium tuberculosis
Mary A. De Groote et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
Jakko van Ingen et al.
CLINICAL INFECTIOUS DISEASES (2011)
Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics
Juan David Guzman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Molecular Bacterial Load Assay, a Culture-Free Biomarker for Rapid and Accurate Quantification of Sputum Mycobacterium tuberculosis Bacillary Load during Treatment
Isobella Honeyborne et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Characterization and Transcriptome Analysis of Mycobacterium tuberculosis Persisters
Iris Keren et al.
MBIO (2011)
Resuscitation-promoting Factors Reveal an Occult Population of Tubercle Bacilli in Sputum
Galina V. Mukamolova et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism
Mi-Jeong Kim et al.
EMBO MOLECULAR MEDICINE (2010)
Resuscitation-promoting factors as lytic enzymes for bacterial growth and signaling
Bavesh Davandra Kana et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2010)
Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!
Leonard Amaral et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis
Juan D. Guzman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Animal models of tuberculosis
Douglas Young
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Bioactive Pyridine-N-oxide Disulfides from Allium stipitatum
Gemma O'Donnell et al.
JOURNAL OF NATURAL PRODUCTS (2009)
Foamy macrophages and the progression of the human tuberculosis granuloma
David G. Russell et al.
NATURE IMMUNOLOGY (2009)
A Novel In Vitro Multiple-Stress Dormancy Model for Mycobacterium tuberculosis Generates a Lipid-Loaded, Drug-Tolerant, Dormant Pathogen
Chirajyoti Deb et al.
PLOS ONE (2009)
Arylamine N-acetyltransferases in mycobacteria
Edith Sim et al.
CURRENT DRUG METABOLISM (2008)
Confronting the scientific obstacles to global control of tuberculosis
Douglas B. Young et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro
Bavesh D. Kana et al.
MOLECULAR MICROBIOLOGY (2008)
Innate immunity in tuberculosis: myths and truth
Daniel S. Korbel et al.
MICROBES AND INFECTION (2008)
Mycobacterial persistance requires the utilization of host cholesterol
Amit K. Pandey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Resuscitation-promoting factors are expressed in Mycobacterium tuberculosis-infected human tissue
A. P. Davies et al.
TUBERCULOSIS (2008)
Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum
Natalie J. Garton et al.
PLOS MEDICINE (2008)
Biomarkers of treatment response in clinical trials of novel antituberculosis agents
Felicity M. R. Perrin et al.
LANCET INFECTIOUS DISEASES (2007)
Isoniazid activity is terminated by bacterial persistence
Denis A. Mitchison et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis
JM Tufariello et al.
INFECTION AND IMMUNITY (2006)
Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension
MC Tsai et al.
CELLULAR MICROBIOLOGY (2006)
Wake up! Peptidoglycan lysis and bacterial non-growth states
Nicholas H. Keep et al.
TRENDS IN MICROBIOLOGY (2006)
The structure of a resuscitation-promoting factor domain from Mycobacterium tuberculosis shows homology to lysozymes
M Cohen-Gonsaud et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Target-based drug discovery: is something wrong?
F Sams-Dodd
DRUG DISCOVERY TODAY (2005)
The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism -: Novel insights into drug mechanisms of action
HIM Boshoff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Individual Mycobacterium tuberculosis resuscitation-promoting factor homologues are dispensable for growth in vitro and in vivo
JM Tufariello et al.
INFECTION AND IMMUNITY (2004)
In situ study of abundant expression of proinflammatory chemokines and cytokines in pulmonary granulomas that develop in cynomolgus macaques experimentally infected with Mycobacterium tuberculosis
CL Fuller et al.
INFECTION AND IMMUNITY (2003)
In situ detection of Mycobacterium tuberculosis transcripts in human lung granulomas reveals differential gene expression in necrotic lesions
G Fenhalls et al.
INFECTION AND IMMUNITY (2002)
Innate immunity to Mycobacterium tuberculosis
R van Crevel et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling
JC Betts et al.
MOLECULAR MICROBIOLOGY (2002)
Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia - Reappraising the estimates of risk
GB Marks et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Predicting the outcome of therapy for pulmonary tuberculosis
RS Wallis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
